Vertex Pharmaceuticals Inc has gained US approval for the first new type of painkiller in more than two decades, paving the way for a safer alternative to addictive opioids that have been linked to hundreds of thousands of deaths.
Vertex’s pill, called Journavx, received US Food and Drug Administration clearance to treat moderate to severe acute pain, a statement said on Thursday. The wholesale acquisition cost for the twice-daily medicine is set at US$15.50 per 50 milligram tablet, Vertex said.
Each year, about 125 million opioid prescriptions are written for Americans with pain caused by broken bones, burns, surgeries, and other injuries and procedures. More than half a million US deaths were linked to overdoses of the addictive drugs from 1999 to 2019, official figures show, with more than 70,000 in the year through June last year alone.
Photo:AP
While some fatalities involved use of illicit drugs, many people begin taking them after they lost access to prescribed opioids, leading doctors and health officials to look for other options.
Vertex’s drug has been hailed as a scientific breakthrough, because it allays pain without entering the brain, minimizing the risk of addiction and dependence that can lead patients to ramp up doses to dangerous levels. It is a key to Vertex’s strategy of diversifying beyond its core business centered on cystic fibrosis treatments.
While some analysts predict the painkiller would become a multibillion-dollar product for a company needing a growth driver, questions remain about its price and commercial potential. Health insurers and hospitals might continue steering patients to opioids, which — while dangerous — are cheap and effective.
Vertex has been pressing Congress to create policies that would help its product succeed. For example, the No Pain Act, which provides extra Medicare reimbursement to hospitals that prescribe alternatives to opioids, went into effect this year.
The company plans to focus on selling its drug to the about 2,000 US hospitals that see about two-thirds of patients in acute pain, chief operating officer Stuart Arbuckle said.
Boston-based Vertex, the maker of cystic fibrosis treatments like the blockbuster Trikafta, has worked for more than two decades to develop a nonaddictive pain drug. Journavx, also called suzetrigine, blocks a structure in the nerve cells that send pain signals to the brain.
In late-stage studies of patients with acute pain after surgery, Vertex’s drug worked better than a placebo, but failed to reduce pain faster than a combination of acetaminophen, better known as Tylenol, and an opioid. That could present a challenge for Vertex, as new drugs typically must outperform what is already on the market to gain traction.
Vertex is studying the same pill to treat chronic pain lasting at least three months, which affects about 50 million Americans. The company encountered a setback in December when a mid-stage trial showed the drug failed to work better than a placebo in lower back pain, causing the shares to plunge.
Philippine President Ferdinand Marcos Jr has fired his national police chief, who gained attention for leading the separate arrests of former Philippine president Rodrigo Duterte on orders of the International Criminal Court and televangelist Apollo Carreon Quiboloy, who is on the FBI’s most-wanted list for alleged child sex trafficking. Philippine Executive Secretary Lucas Bersamin did not cite a reason for the removal of General Nicolas Torre as head of the 232,000-member national police force, a position he was appointed to by Marcos in May and which he would have held until 2027. He was replaced by another senior police general, Jose
STILL AFLOAT: Satellite images show that a Chinese ship damaged in a collision earlier this month was under repair on Hainan, but Beijing has not commented on the incident Australia, Canada and the Philippines on Wednesday deployed three warships and aircraft for drills against simulated aerial threats off a disputed South China Sea shoal where Chinese forces have used risky maneuvers to try to drive away Manila’s aircraft and ships. The Philippine military said the naval drills east of Scarborough Shoal (Huangyan Island, 黃岩島) were concluded safely, and it did not mention any encounter with China’s coast guard, navy or suspected militia ships, which have been closely guarding the uninhabited fishing atoll off northwestern Philippines for years. Chinese officials did not immediately issue any comment on the naval drills, but they
POWER CONFLICT: The US president threatened to deploy National Guards in Baltimore. US media reports said he is also planning to station troops in Chicago US President Donald Trump on Sunday threatened to deploy National Guard troops to yet another Democratic stronghold, the Maryland city of Baltimore, as he seeks to expand his crackdown on crime and immigration. The Republican’s latest online rant about an “out of control, crime-ridden” city comes as Democratic state leaders — including Maryland Governor Wes Moore — line up to berate Trump on a high-profile political stage. Trump this month deployed the National Guard to the streets of Washington, in a widely criticized show of force the president said amounts to a federal takeover of US capital policing. The Guard began carrying
Ukrainian drone attacks overnight on several Russian power and energy facilities forced capacity reduction at the Kursk Nuclear Power Plant and set a fuel export terminal in Ust-Luga on fire, Russian officials said yesterday. A drone attack on the Kursk nuclear plant, not far from the border with Ukraine, damaged an auxiliary transformer and led to 50 percent reduction in the operating capacity at unit three of the plant, the plant’s press service said. There were no injuries and a fire sparked by the attack was promptly extinguished, the plant said. Radiation levels at the site and in the surrounding
RSS